Healthium Medtech introduces surgical wound dressing with patented infection prevention technology
Mumbai, India: Healthium Medtech today announced the launch of TRUSHIELD™ NXT surgical wound dressing products on its segments. In addition to wound care, Healthium’s current product portfolio focuses on advanced surgery, urology, and arthroscopy products covering 52,000 stock-keeping units.
As of fiscal 2021, Healthium is India’s largest independent medical device company and the second-largest company overall, in the surgical consumables market. In the non-captive surgical needles segment, it is the largest manufacturer globally, by volume, and the third-largest company overall in the urology collection devices market in the U.K, as of 31st March 2021. As of fiscal 2021, one in five surgeries conducted globally uses a Healthium product.
The announcement comes after Healthium’s acquisition of CareNow Medical last month. As of July 31, 2021, the company has 21 patents in India and 11 patents in the United States, and a further 22 and 6patent applications pending approval in India and US, respectively. With the acquisition of CareNow, the company has acquired an additional portfolio of one patent each in India, the US, and Europe and one patent application pending approval in India.
TRUSHIELD™ NXT combines the advantages of a 3D hydrocellular substrate and patented infection prevention technology to offer a complete wound care system that provides 360-degree wound protection. It provides exudate and moisture management while remaining waterproof. Its patented technology continuously inhibits pathogen growth with a unique non-leaching, non-depleting kill mechanism. It has patents in the U.S, Europe, and India.
The advanced wound care market is expected to grow at a CAGR of 8.8%*. Dominated by traditional wound dressing such as cotton gauze, the Advanced wound dressing category has lagged in penetration because of the high pricing of products and limited availability. TRUSHIELD™ NXT is non-adherent (does not stick to the wound and can be easily removed) and waterproof with exudate management ability when compared to traditional wound dressing and reduces the need to repeatedly change dressings, thereby reducing costs.
Speaking on the new product launch Anish Bafna, CEO and MD, Healthium Medtech, said, “We are excited to add TRUSHIELD™ NXT to strengthen our wound care and post-surgical care portfolio. Aligned to our vision “Access to precision Medtech for every patient, globally”, TRUSHIELD™ NXT is manufactured to high-quality standards at our US FDA registered plant. With our sales network reaching 90% of districts in India with secondary healthcare facilities catering to 40,000 surgeons across 18000 hospitals, we look to offering wider choices to our customers and delivering better standards in patient care, with innovative and quality products.”
Dr. Ashok Moharana, Chief Medical Officer, Healthium Medtech said, “A successful surgery is complemented by a well-healed wound. TRUSHIELD™ NXT surgical wound dressing enables healing through exudate and moisture management ability while providing infection control with a patented technology that continuously inhibits the growth of pathogen ( 99.99% kill rate against a broad spectrum of the pathogen). The dressing is waterproof and does not adhere to the wound, for a trauma-less removal. We believe that with this new technology and our access, we will be able to benefit patients globally.”
